Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cabins, castles, and constant hearts: rhythm control therapy in patients with atrial fibrillation
Stephan Willems, Christian Meyer, Joseph de Bono, et al.
European Heart Journal (2019) Vol. 40, Iss. 46, pp. 3793-3799c
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Early Rhythm-Control Therapy in Patients with Atrial Fibrillation
Paulus Kirchhof, A. John Camm, Andreas Goette, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 14, pp. 1305-1316
Open Access | Times Cited: 1561
Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure
Andreas Rillig, Christina Magnussen, Ann‐Kathrin Ozga, et al.
Circulation (2021) Vol. 144, Iss. 11, pp. 845-858
Open Access | Times Cited: 168
The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation
A. John Camm, Gerald V. Naccarelli, Suneet Mittal, et al.
Journal of the American College of Cardiology (2022) Vol. 79, Iss. 19, pp. 1932-1948
Open Access | Times Cited: 127
Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study
Daehoon Kim, Pil‐Sung Yang, Seng Chan You, et al.
BMJ (2021), pp. n991-n991
Open Access | Times Cited: 125
Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial
Lars Eckardt, Susanne Sehner, Anna Suling, et al.
European Heart Journal (2022) Vol. 43, Iss. 40, pp. 4127-4144
Open Access | Times Cited: 70
Atrial fibrillation burden: a new outcome predictor and therapeutic target
Nina Becher, Andreas Metzner, Tobias Toennis, et al.
European Heart Journal (2024) Vol. 45, Iss. 31, pp. 2824-2838
Open Access | Times Cited: 25
Predicting recurrent atrial fibrillation after catheter ablation: a systematic review of prognostic models
Janine Dretzke, Naomi Chuchu, Ridhi Agarwal, et al.
EP Europace (2020) Vol. 22, Iss. 5, pp. 748-760
Open Access | Times Cited: 103
Supervised Obesity Reduction Trial for AF ablation patients: results from the SORT-AF trial
Nele Geßler, Stephan Willems, Daniel Steven, et al.
EP Europace (2021) Vol. 23, Iss. 10, pp. 1548-1558
Open Access | Times Cited: 62
Effects of Atrial Fibrillation on the Human Ventricle
Steffen Pabel, Maria Knierim, Thea Stehle, et al.
Circulation Research (2022) Vol. 130, Iss. 7, pp. 994-1010
Open Access | Times Cited: 54
Atualização de Tópicos Emergentes da Diretriz Brasileira de Insuficiência Cardíaca – 2021
Fabiana G. Marcondes‐Braga, Lídia Zytynski Moura, Victor Sarli Issa, et al.
Arquivos Brasileiros de Cardiologia (2021)
Open Access | Times Cited: 49
Comorbidities in heart failure with preserved ejection fraction
Andrea Simone Deichl, Rolf Wachter, Frank Edelmann
Herz (2022) Vol. 47, Iss. 4, pp. 301-307
Open Access | Times Cited: 36
MRI-Detected Brain Lesions and Cognitive Function in Patients With Atrial Fibrillation Undergoing Left Atrial Catheter Ablation in the Randomized AXAFA-AFNET 5 Trial
Karl Georg Hæusler, Felizitas A. Eichner, Peter U. Heuschmann, et al.
Circulation (2022) Vol. 145, Iss. 12, pp. 906-915
Open Access | Times Cited: 30
Benefits of early rhythm control of atrial fibrillation
Lars Eckardt, Julian Wolfes, Gerrit Frommeyer
Trends in Cardiovascular Medicine (2023) Vol. 34, Iss. 5, pp. 288-294
Closed Access | Times Cited: 18
Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial
Andreas Metzner, Anna Suling, Axel Brandes, et al.
EP Europace (2021) Vol. 24, Iss. 4, pp. 552-564
Open Access | Times Cited: 39
Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank
Shinwan Kany, Victor Roth Cardoso, Laura Bravo, et al.
Heart (2022) Vol. 108, Iss. 23, pp. 1873-1880
Open Access | Times Cited: 25
Optimal Rhythm Control Strategy in Patients With Atrial Fibrillation
Daehoon Kim, Pil‐Sung Yang, Boyoung Joung
Korean Circulation Journal (2022) Vol. 52, Iss. 7, pp. 496-496
Open Access | Times Cited: 24
Holistic Approaches to Arrhythmia Management: Combining Medication, Ablation, and Device Interventions
Mitul Hareshkumar Chaudhary, Shah Dev, Ankeeta Kumari, et al.
Cureus (2023)
Open Access | Times Cited: 15
Genetics and Pharmacogenetics of Atrial Fibrillation
Asia Owais, Miles Barney, Olivia T Ly, et al.
JACC Basic to Translational Science (2024) Vol. 9, Iss. 7, pp. 918-934
Open Access | Times Cited: 5
Thromboembolic risk and oral anticoagulation in subclinical atrial fibrillation
Felix K. Wegner, Lars Eckardt
Trends in Cardiovascular Medicine (2024)
Open Access | Times Cited: 5
Insights into the Role of Galectin-3 as a Diagnostic and Prognostic Biomarker of Atrial Fibrillation
Yasmin Mohtasham Kia, Alessandro Cannavò, Pegah Bahiraie, et al.
Disease Markers (2023) Vol. 2023, pp. 1-13
Open Access | Times Cited: 11
Association of rhythm control with incident dementia among patients with atrial fibrillation: a nationwide population-based cohort study
Daehoon Kim, Pil‐Sung Yang, Seng Chan You, et al.
Age and Ageing (2021) Vol. 51, Iss. 1
Open Access | Times Cited: 26
The effect of treatment strategy on long-term follow-up results in patients with nonvalvular atrial fibrillation in Turkey: AFTER-2 subgroup analysis
Raif Kılıç, Tuncay Güzel, Adem Aktan, et al.
Aging Clinical and Experimental Research (2023) Vol. 35, Iss. 8, pp. 1695-1704
Closed Access | Times Cited: 9
Catheter‐based ablation to improve outcomes in patients with atrial fibrillation and heart failure with preserved ejection fraction: Rationale and design of the CABA‐HFPEF‐DZHK27 trial
Abdul Shokor Parwani, Stefan Kääb, Tim Friede, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 10, pp. 2203-2212
Open Access | Times Cited: 3
Pulmonary Vein Isolation or Pace and Ablate in Elderly Patients With Persistent Atrial Fibrillation (ABLATE Versus PACE)—Rationale, Methods, and Design
Andreas A. Boehmer, Bernhard M. Kaess, Christian Ruckes, et al.
Canadian Journal of Cardiology (2024)
Open Access | Times Cited: 3
Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option
Manuel Kraft, Antonius Büscher, Felix Wiedmann, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top